Deciphera Pharmaceuticals, Inc. (DCPH)
| Previous close | 14.67 |
| Open | 14.70 |
| Bid | 14.62 x 100 |
| Ask | 14.70 x 100 |
| Day's range | 14.58 - 14.84 |
| 52-week range | 9.90 - 17.73 |
| Volume | |
| Avg. volume | 516,206 |
| Market cap | 1.184B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.29 |
| Earnings date | 01 May 2024 - 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 24.20 |
ZacksDeciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Deciphera Pharmaceuticals (DCPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insider Monkey11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]
Business WireDeciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
WALTHAM, Mass., April 09, 2024--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in a fireside chat at the Stifel 2024 Virtual Targeted Oncology Forum on Tuesday, April 16, 2024 at 11:30 AM ET.
